Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma
Authors:
- 21 March 2015
- journal article
- letter
- Published by Springer Nature in Medical Oncology
- Vol. 32 (4) , 128
Abstract
Hepatocellular carcinoma (HCC) is one of the malignant tumors and leads to the highly death in the solid tumors, but its mechanism remains unclear. KPNβ1 is one of the soluble nuclear transport receptors, has been reported to act as an important role in the occurrence and development of tumor, such as cervical cancer, head and neck and lung cancer. However, the expression mechanisms and physiological significance of KPNβ1 in HCC is still unclear.Keywords
This publication has 33 references indexed in Scilit:
- Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cellsCarcinogenesis, 2014
- EZH2–miR‐30d–KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesisThe Journal of Pathology, 2013
- A Review of Molecular Mechanisms in the Development of Hepatocellular Carcinoma by Aflatoxin and Hepatitis B and C VirusesJournal of Environmental Pathology, Toxicology and Oncology, 2013
- Overexpression of Forkhead Box C1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular CarcinomaHepatology, 2012
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Karyopherins: from nuclear-transport mediators to nuclear-function regulatorsTrends in Cell Biology, 2004
- Nuclear transport as a target for cell growthDrug Discovery Today, 2003
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- Evidence for Distinct Substrate Specificities of Importin α Family Members in Nuclear Protein ImportMolecular and Cellular Biology, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998